Meta-analysis of 8 prospective studies (203 treated patients) of gene therapy for neovascular AMD: no significant BCVA gain (MD 0.54 letters, 95% CI -7.38 to 8.46), but central subfield thickness fell; about 44% of eyes needed rescue anti-VEGF.
Meta-analysisn = 203
Chen et al. Efficacy and Safety of Gene Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis